NCT07250958 Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage
| NCT ID | NCT07250958 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Louisville |
| Condition | Aneurysmal Subarachnoid Hemorrhage |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-03-12 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2026-03-12 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * CT confirmed aSAH with an angiographically detected aneurysm * World Federation of Neurological Sciences (WFNS) aSAH grade 3-5 aneurysm * LAR available and gives consent within 72 hours after the onset of aSAH (or last known normal Exclusion Criteria: * Patients whose aneurysm judged appropriate for balloon-assisted coiling * Patients whose aneurysm is bleeding from the "neck" * Patients who are clinically judged to suffer imminent death within 24 hours. * Pregnancy or positive urine pregnancy test
Frequently Asked Questions
Who can join the NCT07250958 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aneurysmal Subarachnoid Hemorrhage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07250958 currently recruiting?
Yes, NCT07250958 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Louisville to inquire about joining.
Where is the NCT07250958 trial being conducted?
This trial is being conducted at Louisville, United States.
Who is sponsoring the NCT07250958 clinical trial?
NCT07250958 is sponsored by University of Louisville. The trial plans to enroll 30 participants.